A randomized, double-blind, placebo-controlled, Proof of Concept, study of 12 week treatment with RBx 10017609 in subjects with moderate to severe chronic obstructive pulmonary disease (COPD).

Trial Profile

A randomized, double-blind, placebo-controlled, Proof of Concept, study of 12 week treatment with RBx 10017609 in subjects with moderate to severe chronic obstructive pulmonary disease (COPD).

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 24 Aug 2016

At a glance

  • Drugs RBx 10017609 (Primary)
  • Indications Chronic obstructive pulmonary disease
  • Focus Adverse reactions
  • Most Recent Events

    • 25 Sep 2013 Status changed from recruiting to active, no longer recruiting as reported by Clinical Trials Registry - India.
    • 27 Mar 2012 New source identified and integrated (EudraCT2010-024640-15; European Clinical Trials Database).
    • 04 Oct 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top